Results 1 to 10 of about 240,071 (288)

Genetic Variants Associated with Life Expectancy in Patients with Chagas Disease [PDF]

open access: yesMedical Sciences
Single nucleotide polymorphisms (SNPs), as common genetic variations, can influence biological processes. Identifying these variations is crucial for recognizing high-risk subgroups, guiding preventive strategies, and enabling personalized management ...
Mario Bruno Principato   +10 more
doaj   +2 more sources

Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults [PDF]

open access: yes, 2014
Introduction:Chagas disease, caused by the parasite Trypanosoma cruzi, can lead to long term cardiac morbidity. Treatment of children with benznidazole is effective, but no pediatric pharmacokinetics data are available and clinical pharmacology ...
Altcheh, Jaime Marcelo   +9 more
core   +35 more sources

The Learning Curve for Peroral Endoscopic Myotomy in Latin America: A Slide to the Right? [PDF]

open access: yesClinical Endoscopy, 2021
Background/Aims Peroral endoscopic myotomy (POEM) has been increasingly used for achalasia in Latin America, where Chagas disease is prevalent, and this makes POEM more challenging.
Michel Kahaleh   +23 more
doaj   +1 more source

Seroprevalencia de la enfermedad de Chagas (Trypanosoma cruzi) en la población escolar e incidencia parasitaria de Triatoma dimidiata en la parroquia Juan Gómez Rendón, Provincia del Guayas, Ecuador

open access: yesRevista Científica de Ciencias Naturales y Ambientales, 2021
Se realizaron encuestas serológicas y entomológicas para determinar la prevalencia de la enfermedad de Chagas, la presencia del vector y el índice tripano triatomino, en la población escolar de la parroquia Juan Gómez Rendón, en la provincia del Guayas,
Verónica Calderón, Jaime Buestán
doaj   +1 more source

In Silico Antiprotozoal Evaluation of 1,4-Naphthoquinone Derivatives against Chagas and Leishmaniasis Diseases Using QSAR, Molecular Docking, and ADME Approaches

open access: yesPharmaceuticals, 2022
Chagas and leishmaniasis are two neglected diseases considered as public health problems worldwide, for which there is no effective, low-cost, and low-toxicity treatment for the host.
Lina S. Prieto Cárdenas   +6 more
doaj   +1 more source

Epidemiologia de Triatominos en la Provincia de Río Negro

open access: yesCiencia Veterinaria, 2021
Chagas es una enfermedad endemoepidémica de transmisión vec-torial en la Provincia de Rio Negro causada por Trypanosoma cruzi, transmitido por insectos vectores denominados triatominos (vinchu-cas).
Crowley P   +9 more
doaj   +1 more source

Chagas Disease [PDF]

open access: yesPediatrics In Review, 2016
Approximately 8 million people worldwide are infected by the protozoan parasite Trypanosoma cruzi, the causative agent of Chagas disease. After a latent period that can last years or decades, 10% to 30% of infected people develop serious complications, such as cardiomyopathy or gastrointestinal dysfunction.
Tustin, Aaron W., Bowman, Natalie M.
openaire   +2 more sources

One-Pot Multicomponent Synthesis of Methoxybenzo[h]quinoline-3-carbonitrile Derivatives; Anti-Chagas, X-ray, and In Silico ADME/Tox Profiling Studies

open access: yesMolecules, 2021
Several methoxybenzo[h]quinoline-3-carbonitrile analogs were designed and synthesized in a repositioning approach to developing compounds with anti-prostate cancer and anti-Chagas disease properties.
Hegira Ramírez   +6 more
doaj   +1 more source

Mitochondrial DNA Haplogroups and Variants Predispose to Chagas Disease Cardiomyopathy

open access: yesHearts, 2023
Cardiomyopathies are major causes of heart failure. Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central and South America.
Frédéric Gallardo   +39 more
doaj   +1 more source

Home - About - Disclaimer - Privacy